Skip to content
Home/Companies/Biotech/Alcolase

Alcolase

Biotech·Denmark·Active·New
Entry
2026
Hold
New
Status
Active

Who owns Alcolase?

Alcolase is a Danish Biotech company, currently owned by Delphinus Venture Capital since 2026.

Hand-verified · updated 2026-08-19

Open JSON · CC-BY
Delphinus Venture Capital
Investor
Delphinus Venture Capital
Delphinus Evergreen Fund · 2025 · VC

Key facts

HQDenmark
SectorBiotech
StatusActive

More from Delphinus Evergreen Fund

Other portfolio companies in the same fund.

Ardos
Active
MedTechDenmark· 2026
Cordulus
Active
AgTechDenmark· 2026
Cystotech
Active
MedTechDenmark· 2026
Decameal
Active
FoodTechDenmark· 2026
EtOH Spirits
Active
FoodTechDenmark· 2026
Kvantify
Active
Deep TechDenmark· 2026

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Alcolase?

Alcolase is currently owned by Delphinus Venture Capital, through Delphinus Evergreen Fund, since 2026.

When did Delphinus Venture Capital acquire Alcolase?

Delphinus Venture Capital acquired Alcolase in 2026.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue